Overview

VIVIO Health uses patient-specific data to guide specialty drug decisions for individuals, not populations. Its product, VIVIO Precision Care, analyzes real-world outcomes to identify which specialty therapies will work and be cost-effective for a patient, addressing high-cost, low-effectiveness treatments and the pharma-centric model. It differs from competitors by focusing on real-world, individual-level data to align drug choices with patient outcomes rather than policy or opinion, reducing supply chain waste. The goal is to improve patient outcomes while lowering total costs for self-insured employers, typically saving 25-35% of spend.